FDA Electronic Submissions Gateway (ESG) User Guide ... - ICON plc

FDA Electronic Submissions Gateway (ESG) User Guide ... - ICON plc FDA Electronic Submissions Gateway (ESG) User Guide ... - ICON plc

10.07.2015 Views

eCTD – Electronic Common Technical DocumentIDE – Investigational Device ExemptionIND – Investigational New Drug Application (eCTD and eIND format)DMF – Drug Master FilePromotional MaterialsLot Distribution DataAERS – Adverse Event ReportsAERS AttachmentsANDA – Abbreviated New Drug ApplicationCDERBLA – Biologics License Application (eCTD and eBLA format)eCTD – Electronic Common Technical DocumentNDA – New Drug Application (eCTD and eNDA format)CDRHCVMOCGWTEST*IND – Investigational New Drug ApplicationAdverse EventsElectronic SubmissionsElectronic SubmissionsSLP - Structured Product Labeling (includes NDC Labeler Code Request,Establishment Registration and Drug Listing)CONNECTION TESTSIZE TEST* These submission types are only supported in the Test environment and are intended solely fortesting.3.4 Naming ConventionsA special consideration applies to the naming convention for files and directories. The followingcharacters are not recommended for use when naming submission files and directories:

- forward slash\ - backslash: - colon? - question mark" - quotation marks< - less than sign> - greater than sign| - vertical bar,space - If you need to use a space, use_an_underscore_instead orSeparateWordsWithCapitalLetters.Note: Directories and sub-directories cannot begin with the "." (dot) character.3.5 Determine Submission MethodThere are three options for sending FDA ESG submissions:FDA ESG Web Interface – The FDA ESG Web Interface sends submissions via Hyper TextTransfer Protocol Secure (HTTPS) through a web browser according to Applicability Statement2 (AS2) standards.Applicability Statement 2 (AS2) Gateway-to-Gateway – An electronic submission protocol thatuses HTTP/HTTPS for communications.Determining the best of these options for your organization will be influenced by the types ofsubmissions to be transmitted, infrastructure capabilities, and business requirements.One or more of these options can be selected to submit electronic documents to the FDA.However, a separate registration will be required for each option selected.Considerations for each option are shown in Table 3 below.Table 3: Considerations for Submission Protocol ChoiceAS2FDA ESG Web InterfaceGateway-to-GatewayCost None High setup and support costsSetup Minimal Need to install and configure GatewayUser-friendly webinterfaceYesNoSubmission typessupportedAll, including AERSreportsLong-term support by Yes YesAll, including AERS reports

eCTD – <strong>Electronic</strong> Common Technical DocumentIDE – Investigational Device ExemptionIND – Investigational New Drug Application (eCTD and eIND format)DMF – Drug Master FilePromotional MaterialsLot Distribution DataAERS – Adverse Event ReportsAERS AttachmentsANDA – Abbreviated New Drug ApplicationCDERBLA – Biologics License Application (eCTD and eBLA format)eCTD – <strong>Electronic</strong> Common Technical DocumentNDA – New Drug Application (eCTD and eNDA format)CDRHCVMOCGWTEST*IND – Investigational New Drug ApplicationAdverse Events<strong>Electronic</strong> <strong>Submissions</strong><strong>Electronic</strong> <strong>Submissions</strong>SLP - Structured Product Labeling (includes NDC Labeler Code Request,Establishment Registration and Drug Listing)CONNECTION TESTSIZE TEST* These submission types are only supported in the Test environment and are intended solely fortesting.3.4 Naming ConventionsA special consideration applies to the naming convention for files and directories. The followingcharacters are not recommended for use when naming submission files and directories:

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!